Close
Novotech
Jabsco PureFlo 21 Single Use

News

Pharmaceutical outsourcing partner predicts AI and dialogue cues will assist HCP engagement

How can pharmaceutical companies leverage digital to engage HCPs in a complex healthcare environment? Digital transformation has been the leading topic of discussion in most industries this year, and healthcare is no exception. Although, it would be unfair to dismiss...

U.S. FDA Approves BMS’s Breyanzi, a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma

Bristol Myers Squibb announced that the U.S. FDA has approved Breyanzi, a CD19-directed chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) after two or more...

Lebanon authorises emergency use of Russias Sputnik V vaccine

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of Lebanon. The vaccine was approved under the emergency use authorization procedure without additional...

Sepha launches small batch Contract Packaging Service

We are excited to announce the launch of a contract packaging service to meet rising demand for small batch production. Aimed at the pharmaceutical, nutraceutical and medical device industries, Sepha’s new contract packaging offer is focused on providing cost-effective,...

Turkish Cargo is steering the future of the industry with the digital event “Cargo Talks”

Turkish Cargo is organizing a webinar titled “Cargo Talks” during which the valuable stakeholders of the air cargo industry, who finger on the pulse of the industry, will exchange opinions, and the important agenda items such as digitalization, vaccine...

CSafe Global Continues Expansion Across Asia with Two New Hub Locations in China

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, continues to expand operations across Asia opening two new hub operations in Beijing and Guangzhou, China. The Beijing (PEK) facility will provide 500 sqm (5382...

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the potential for a multi-valent approach to address multiple emerging variants in one vaccine. GSK...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »